Beijing Enterprises Medical and Health Industry Gr : Announcements and Notices - Voluntary Announcement - Share Buyback

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(Incorporated in the Cayman Islands with limited liability)

(Stock code: 2389) VOLUNTARY ANNOUNCEMENT SHARE BUYBACK

This is a voluntary announcement made by Beijing Enterprises Medical and Health Industry Group Limited (the "Company").

The board of directors (the "Board") of the Company hereby announces that it has exercised its power under the general mandate to buyback (the "Share Buy-back Mandate") shares of the Company (the "Shares") granted by the shareholders of the Company (the "Shareholders") to the Board at the annual general meeting (the "AGM") of the Company held on 20 May 2016.

On 19 September 2016, the Company bought back on market a total of 7,686,000 Shares, representing approximately 0.12% of the issued share capital of the Company as at the date of AGM. The highest purchase price per Share was HK$0.435, the lowest purchase price per Share was HK$0.420 and the average purchase price per Share was approximately HK$0.425. The aggregate consideration for the buy-back of Shares is HK$3,264,240.00 (before brokerage and expenses). The Company may make further buybacks depending on market conditions.

Pursuant to the Share Buy-back Mandate, the Company is allowed to buy-back up to 625,776,234 Shares, being 10% of the total number of issued Shares as at the date of the AGM, on The Stock Exchange of Hong Kong Limited (the "Proposed Share Buy-back"). The Company will conduct the Proposed Share Buy-back in compliance with all applicable regulations and rules that the Company is subject to.

The Board believes that the Shares have been trading at a level which undervalues the Company's performance, assets' value and business prospects. Since the Board is committed to actively managing the Company's capital, the Board believes that the Proposed Share Buy- back is in the interests of the Company and Shareholders as a whole.

The Board also believes that the Company's solid financial position will enable it to conduct the Proposed Share Buy-back while maintaining sufficient resources for the continued growth of the Company's operation. The Proposed Share Buy-back also reflects the confidence of the Board in the prospects of the Company.

Shareholders and potential investors should note that the exercise of the Share Buy-back Mandate by the Company will be subject to market conditions and will be at the absolute discretion of the Board. There is no assurance of the timing, quantity or price of any Share Buy-back. Shareholders and potential investors should exercise caution when dealing in the Shares.

Hong Kong, 21 September 2016

By Order of the Board of

Beijing Enterprises Medical and Health Industry Group Limited Zhu Shi Xing

Chairman

As at the date of this announcement, the Board comprises seven Executive Directors, namely Mr. Zhu Shi Xing, Mr. Liu Xue Heng, Mr. Gu Shan Chao, Mr. Hu Xiao Yong, Mr. Hu Shiang Chi, Mr. Wang Zheng Chun and Mr. Zhang Jing Ming; one Non-Executive Director, namely Mr. Robert Winslow Koepp and four Independent Non-Executive Directors, namely Mr. Gary Zhao, Mr. Tse Man Kit, Keith, Mr. Wu Yong Xin and Mr. Zhang Yun Zhou.